This is a StreetInsider.com Premium Only Page

(VRNA) –

Apr 25, 2024 02:00 AM Verona Pharma to Report First Quarter 2024 Financial Results and Provide Corporate Update

Apr 23, 2024 04:06 PM Verona Pharma (VRNA) PT Raised to $34 at BTIG

Apr 16, 2024 06:39 AM Verona Pharma (VRNA) PT Raised to $36 at Piper Sandler

Apr 2, 2024 04:15 PM Form 4 Verona Pharma plc For: Apr 01 Filed by: Fisher Andrew

Mar 20, 2024 08:48 AM Form ARS Verona Pharma plc For: Dec 31

Mar 20, 2024 08:47 AM Form DEF 14A Verona Pharma plc For: Apr 26

Mar 12, 2024 07:46 PM Form 144 Verona Pharma plc Filed by: Gupta Rishi

Mar 8, 2024 04:19 PM Form PRE 14A Verona Pharma plc For: Apr 26

Mar 7, 2024 09:41 PM Form 3 Verona Pharma plc For: Mar 04 Filed by: Fisher Andrew

Mar 4, 2024 08:16 PM Form 144 Verona Pharma plc Filed by: ORBIMED ADVISORS LLC

Mar 4, 2024 02:00 AM Andrew Fisher Joins Verona Pharma as General Counsel

Feb 29, 2024 09:03 AM Form 10-K Verona Pharma plc For: Dec 31

Feb 29, 2024 06:32 AM Verona Pharma plc (VRNA) Tops Q4 EPS by 1c

Feb 29, 2024 06:11 AM Form 8-K Verona Pharma plc For: Feb 29

Feb 29, 2024 02:00 AM Verona Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

Feb 27, 2024 07:00 AM Ligand Reports Fourth Quarter and Full Year 2023 Financial Results

Feb 15, 2024 02:00 AM Verona Pharma to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update

Feb 14, 2024 05:02 PM Form SC 13G/A Verona Pharma plc Filed by: RA CAPITAL MANAGEMENT, L.P.

Feb 14, 2024 04:28 PM Form SC 13G/A Verona Pharma plc Filed by: PERCEPTIVE ADVISORS LLC

Feb 9, 2024 10:13 AM Form SC 13G Verona Pharma plc Filed by: FMR LLC

Feb 8, 2024 10:03 AM Form SC 13G Verona Pharma plc Filed by: WELLINGTON MANAGEMENT GROUP LLP

Feb 5, 2024 06:11 PM Form 4 Verona Pharma plc For: Feb 01 Filed by: ZACCARDELLI DAVID

Feb 5, 2024 06:11 PM Form 4 Verona Pharma plc For: Feb 01 Filed by: Poll Claire

Feb 5, 2024 06:11 PM Form 4 Verona Pharma plc For: Feb 01 Filed by: Rickard Kathleen A.

Feb 5, 2024 06:10 PM Form 4 Verona Pharma plc For: Feb 01 Filed by: Hahn Mark W

Feb 5, 2024 04:19 PM Form 144 Verona Pharma plc Filed by: Rickard Kathleen A.

Feb 2, 2024 06:07 AM Form 4 Verona Pharma plc For: Feb 01 Filed by: Austwick Michael

Feb 2, 2024 06:06 AM Form 3 Verona Pharma plc For: Feb 01 Filed by: Austwick Michael

Feb 2, 2024 06:05 AM Form 8-K Verona Pharma plc For: Jan 31

Feb 1, 2024 05:45 AM Verona (VRNA) Appoints Michael Austwick as Non-Executive Director

Feb 1, 2024 02:00 AM Michael Austwick Joins Verona Pharma as Non-Executive Director

Jan 8, 2024 03:00 AM Clarivate Identifies Thirteen Potential Blockbuster Drugs and Gamechangers in Annual Drugs to Watch Report

Jan 3, 2024 02:00 AM Verona Pharma to Present at 42nd Annual J.P. Morgan Healthcare Conference

Jan 2, 2024 06:04 AM Form 8-K Verona Pharma plc For: Dec 27

Jan 2, 2024 04:37 AM Verona Pharma plc (VRNA) Enters $400M Debt Facility with Oxford Finance and Hercules Capital

Jan 2, 2024 02:00 AM Verona Pharma enters into Debt Facility of up to $400 Million with Oxford Finance and Hercules Capital

Dec 18, 2023 04:15 PM Form 8-K Verona Pharma plc For: Dec 14

Nov 22, 2023 05:10 PM Form 4 Verona Pharma plc For: Nov 20 Filed by: Edwards Martin

Nov 17, 2023 02:00 AM Verona Pharma’s President and CEO David Zaccardelli Wins Executive of the Year SCRIP Award

Nov 8, 2023 04:15 PM Form 4 Verona Pharma plc For: Nov 06 Filed by: EBSWORTH DAVID R

Nov 8, 2023 04:01 PM Ligand Reports Third Quarter 2023 Financial Results

Nov 8, 2023 02:00 AM Verona Pharma Announces November 2023 Investor Conference Participation

Nov 3, 2023 08:11 PM Form 4 Verona Pharma plc For: Nov 01 Filed by: Rickard Kathleen A.

Nov 3, 2023 08:10 PM Form 4 Verona Pharma plc For: Nov 01 Filed by: ZACCARDELLI DAVID

Nov 3, 2023 08:10 PM Form 4 Verona Pharma plc For: Nov 01 Filed by: Poll Claire

Nov 3, 2023 08:09 PM Form 4 Verona Pharma plc For: Nov 01 Filed by: Hahn Mark W

Nov 3, 2023 04:26 PM Form 144 Verona Pharma plc Filed by: Rickard Kathleen A.

Nov 2, 2023 04:18 PM Form 10-Q Verona Pharma plc For: Sep 30

Nov 2, 2023 06:25 AM Form 8-K Verona Pharma plc For: Nov 02

Nov 2, 2023 04:25 AM Verona Pharma plc (VRNA) Tops Q3 EPS by 1c